Rare diseases
Investigational molecules
Locations
Back to France681 clinical trials in Angers, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Phase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis
FrancePhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
FranceA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
FranceA study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer
FranceA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
FranceA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
FranceStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
FranceStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
FranceStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
FranceFranceStudy on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen
FranceStudy on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on multiple myeloma, breast cancer, and various forms of lung cancer. Studies are evaluating new combination therapies and treatment approaches for both early-stage and advanced cancers.
Research includes investigation of novel drug combinations and immunotherapy approaches.
Clinical research addressing heart failure prevention and acute myocardial infarction management. Studies are exploring innovative pain management approaches and preventive treatments.
Focus on both acute care solutions and long-term prevention strategies.
Comprehensive research in kidney transplantation and immune disorders, including studies on preventing rejection and managing immunosuppression.
Trials aim to improve long-term outcomes for transplant recipients and immune disorder patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
